STOCK ALARM
PRO
SA
PRO
Market
Screener
Alerts
⌘
K
LON
NYC
Crypto
Pro
Sign In
Free Account
Skye Bioscience, Inc.
SKYE
NASDAQ
LOADING
|
|
|
Overview
Charts
News
Fundamentals
Key Metrics
TTM
Financials
Earnings
Growth
Rating
Analysts
Institutional
Peers
Historical
Key Metrics
Explore More
S&P 500 Screener
Filter and sort all 500 stocks
Market Movers
Today's biggest gainers and losers
Market Heatmap
Visual sector performance
As of
2024
• vs 2023
Annual
Quarterly
Per Share
Revenue/Share
$0.00
Net Income/Share
$-0.73
+86.4%
Operating CF/Share
$-0.69
+65.3%
Free CF/Share
$-0.74
+63.1%
Cash/Share
$1.88
+945.6%
Book Value/Share
$1.87
+713.9%
Tangible Book/Share
$1.87
+713.9%
Equity/Share
$1.87
+713.9%
Interest Debt/Share
$0.04
-95.1%
Valuation
Market Cap
$103.26M
+441.9%
Enterprise Value
$35.30M
+57.5%
P/E Ratio
-3.89
-667.8%
P/S Ratio
0.00
P/OCF Ratio
-4.09
-199.6%
P/FCF Ratio
-3.85
-181.9%
P/B Ratio
1.52
+116.9%
P/TB Ratio
1.52
+116.9%
EV/Sales
0.00
EV/EBITDA
-1.40
-128.0%
Profitability
Earnings Yield
-25.73%
+87.0%
FCF Yield
-25.99%
+64.5%
ROE
-38.98%
-102.2%
ROIC
-44.01%
+96.9%
Return on Tangible Assets
-36.51%
+88.4%
Capital Allocation
CapEx/OCF
-6.36%
-6965.8%
CapEx/Revenue
0.00%
CapEx/Depreciation
5.37
+5217.7%
SBC/Revenue
0.00%
Balance Sheet
Debt/Equity
0.01
+100.3%
Debt/Assets
0.01
-98.4%
Net Debt/EBITDA
2.69
+3029.7%
Current Ratio
16.32
+1847.6%
Interest Coverage
-31.20x
+18.6%
Income Quality
0.95
+156.3%
Efficiency
Days Sales Outstanding
0 days
Days Payables Outstanding
0 days
Days Inventory
0 days
Receivables Turnover
0.00x
Payables Turnover
0.00x
Inventory Turnover
0.00x
Special Valuations
Graham Number
--
Graham Net-Net
$1.75
+196.5%